Literature DB >> 16489488

Direct nose-to-brain transfer of morphine after nasal administration to rats.

Ulrika Espefält Westin1, Emma Boström, Johan Gråsjö, Margareta Hammarlund-Udenaes, Erik Björk.   

Abstract

PURPOSE: The aim of this study was to quantify the olfactory transfer of morphine to the brain hemispheres by comparing brain tissue and plasma morphine levels after nasal administration with those after intravenous administration.
METHODS: Morphine (1.0 mg/kg body weight) was administered via the right nostril or intravenously as a 15-min constant-rate infusion to male rats. The content of morphine and its metabolite morphine-3-glucuronide in samples of the olfactory bulbs, brain hemispheres, and plasma was assessed using high-performance liquid chromatography, and the areas under the concentration-time curves (AUC) were calculated.
RESULTS: At both 5 and 15 min after administration, brain hemisphere morphine concentrations after nasal administration were similar to those after i.v. administration of the same dose, despite lower plasma concentrations after nasal administration. The brain hemispheres/plasma morphine AUC ratios for the 0-5 min period were thus approximately 3 and 0.1 after nasal and i.v. administration, respectively, demonstrating a statistically significant early distribution advantage of morphine to the brain hemispheres via the nasal route.
CONCLUSION: Morphine is transferred via olfactory pathways to the brain hemispheres, and drug transfer via this route significantly contributes to the early high brain concentrations after nasal administration to rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489488     DOI: 10.1007/s11095-006-9534-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery.

Authors:  M A Hussain; D Rakestraw; S Rowe; B J Aungst
Journal:  J Pharm Sci       Date:  1990-09       Impact factor: 3.534

2.  An approximate distribution of estimates of variance components.

Authors:  F E SATTERTHWAITE
Journal:  Biometrics       Date:  1946-12       Impact factor: 2.571

3.  Intranasal delivery of morphine.

Authors:  L Illum; P Watts; A N Fisher; M Hinchcliffe; H Norbury; I Jabbal-Gill; R Nankervis; S S Davis
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

4.  The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.

Authors:  J Lötsch; C Skarke; H Schmidt; S Grösch; G Geisslinger
Journal:  Anesthesiology       Date:  2001-12       Impact factor: 7.892

5.  Estimation of variance for AUC in animal studies.

Authors:  J Yuan
Journal:  J Pharm Sci       Date:  1993-07       Impact factor: 3.534

6.  Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

Authors:  H S Chow; Z Chen; G T Matsuura
Journal:  J Pharm Sci       Date:  1999-08       Impact factor: 3.534

7.  Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.

Authors:  M R Bouw; M Gårdmark; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

8.  Systematic review of factors affecting the ratios of morphine and its major metabolites.

Authors:  Clara C Faura; Sally L Collins; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  1998-01       Impact factor: 6.961

9.  Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients.

Authors:  Dermot Fitzgibbon; Donna Morgan; Deanna Dockter; Chris Barry; Evan D Kharasch
Journal:  Pain       Date:  2003-12       Impact factor: 6.961

Review 10.  Nasal administration of opioids for pain management in adults.

Authors:  O Dale; R Hjortkjaer; E D Kharasch
Journal:  Acta Anaesthesiol Scand       Date:  2002-08       Impact factor: 2.105

View more
  24 in total

1.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups.

Authors:  Damon Klebe; Jerry J Flores; Devin W McBride; Paul R Krafft; William B Rolland; Tim Lekic; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2016-12-20       Impact factor: 6.200

4.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

5.  Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats.

Authors:  Noha Nafee; Abd El Rahman Ameen; Osama Y Abdallah
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

6.  Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.

Authors:  John D Hoekman; Rodney J Y Ho
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

7.  Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.

Authors:  Qianwen Wang; Yufeng Zhang; Chun-Ho Wong; H Y Edwin Chan; Zhong Zuo
Journal:  AAPS J       Date:  2017-12-27       Impact factor: 4.009

8.  Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.

Authors:  Brijesh Shah; Dignesh Khunt; Manju Misra; Harish Padh
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

Review 9.  Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.

Authors:  Mitchel J R Ruigrok; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

10.  Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.

Authors:  Deepak Sharma; Rakesh Kumar Sharma; Navneet Sharma; Reema Gabrani; Sanjeev K Sharma; Javed Ali; Shweta Dang
Journal:  AAPS PharmSciTech       Date:  2015-02-21       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.